Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Ghrelin increases intake of rewarding food in rodents.

Egecioglu E, Jerlhag E, Salomé N, Skibicka KP, Haage D, Bohlooly-Y M, Andersson D, Bjursell M, Perrissoud D, Engel JA, Dickson SL.

Addict Biol. 2010 Jul;15(3):304-11. doi: 10.1111/j.1369-1600.2010.00216.x. Epub 2010 May 6.

2.

On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist.

Salomé N, Hansson C, Taube M, Gustafsson-Ericson L, Egecioglu E, Karlsson-Lindahl L, Fehrentz JA, Martinez J, Perrissoud D, Dickson SL.

J Neuroendocrinol. 2009 Sep;21(9):777-85. doi: 10.1111/j.1365-2826.2009.01895.x.

PMID:
19703102
3.

Requirement of central ghrelin signaling for alcohol reward.

Jerlhag E, Egecioglu E, Landgren S, Salomé N, Heilig M, Moechars D, Datta R, Perrissoud D, Dickson SL, Engel JA.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11318-23. doi: 10.1073/pnas.0812809106. Epub 2009 Jun 29.

4.

Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats.

Salomé N, Haage D, Perrissoud D, Moulin A, Demange L, Egecioglu E, Fehrentz JA, Martinez J, Dickson SL.

Eur J Pharmacol. 2009 Jun 10;612(1-3):167-73. doi: 10.1016/j.ejphar.2009.03.066. Epub 2009 Apr 5.

PMID:
19356720
5.

Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.

Bresciani E, Tamiazzo L, Torsello A, Bulgarelli I, Rapetti D, Caporali S, Perrissoud D, Moulin A, Fehrentz JA, Martinez J, Locatelli V.

Eat Weight Disord. 2008 Sep;13(3):e67-74.

PMID:
19011367
6.

New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations.

Moulin A, Demange L, Ryan J, Mousseaux D, Sanchez P, Bergé G, Gagne D, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J.

J Med Chem. 2008 Feb 14;51(3):689-93. doi: 10.1021/jm701292s. Epub 2008 Jan 15.

PMID:
18193826
7.

Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations.

Moulin A, Demange L, Bergé G, Gagne D, Ryan J, Mousseaux D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J.

J Med Chem. 2007 Nov 15;50(23):5790-806. Epub 2007 Oct 10.

PMID:
17927165
8.

A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells.

van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M, van Blitterswijk WJ.

Mol Cancer Ther. 2007 Aug;6(8):2337-45.

9.

Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1.

Demange L, Boeglin D, Moulin A, Mousseaux D, Ryan J, Bergé G, Gagne D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J.

J Med Chem. 2007 Apr 19;50(8):1939-57. Epub 2007 Mar 22.

PMID:
17375904
10.

Synthesis and pharmacological evaluation of new (indol-3-yl)alkylamides and alkylamines acting as potential serotonin uptake inhibitors.

Fouchard F, Menciu C, Duflos M, Le Baut G, Lambrey B, Mourgues M, Perrissoud D.

Arzneimittelforschung. 1999 Feb;49(2):96-105.

PMID:
10083976
11.

Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity.

Carrupt PA, Testa B, Bechalany A, el Tayar N, Descas P, Perrissoud D.

J Med Chem. 1991 Apr;34(4):1272-5.

PMID:
2016703
12.

COR3224--a new antidepressant: pharmacokinetics and metabolism in rat.

Neau B, Damaj I, Lambrey B, Akbaraly JP, Roux J, Perrissoud D, Jacquot J.

Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:77-9.

PMID:
1820940
13.

Flavonoids as inhibitors of rat liver monooxygenase activities.

Beyeler S, Testa B, Perrissoud D.

Biochem Pharmacol. 1988 May 15;37(10):1971-9.

PMID:
3377805
14.

Protective effect of malotilate against galactosamine intoxication in the rat.

Dumont JM, Maignan MF, Perrissoud D.

Arch Int Pharmacodyn Ther. 1987 Oct;289(2):296-310.

PMID:
3426350
15.
16.

Effect of malotilate on chronic liver injury induced by carbon tetrachloride in the rat.

Dumont JM, Maignan MF, Janin B, Herbage D, Perrissoud D.

J Hepatol. 1986;3(2):260-8.

PMID:
3794306
17.

The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.

Perrissoud D.

Prog Clin Biol Res. 1986;213:559-69. No abstract available.

PMID:
3520595
18.

Correlation of antiviral and histamine release-inhibitory activity of several synthetic flavonoids.

Middleton E Jr, Faden H, Drzewiecki G, Perrissoud D.

Prog Clin Biol Res. 1986;213:541-4. No abstract available.

PMID:
2424032
19.

The effect of 3-palmitoyl-(+)-catechin on Kupffer cells in guinea pig liver.

Piazza M, Borgia G, Crowell J, Nappa S, Lambiase A, Perrissoud D, Schreil W.

Hepatology. 1985 Sep-Oct;5(5):867-9.

PMID:
4029897
20.
22.

The effect of cianidanol on rat hepatic monooxygenase activities.

Beyeler S, Testa B, Perrissoud D.

Arzneimittelforschung. 1983;33(4):564-7.

PMID:
6683535
23.

The effect of carbon tetrachloride on isolated rat hepatocytes.

Perrissoud D, Auderset G, Reymond O, Maignan MF.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1981;35(2):83-91.

PMID:
6112817
24.

Protective effect of (+)cyanidanol-3 in acute liver injury induced by galactosamine or carbon tetrachloride in the rat.

Perrissoud D, Weibel I.

Naunyn Schmiedebergs Arch Pharmacol. 1980 Jul;312(3):285-91.

PMID:
7402370

Supplemental Content

Loading ...
Support Center